Is Alvotech SA halal to invest in?

According to Musaffa's Shariah screening methodology, Alvotech SA (ALVO) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Alvotech SA a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Alvotech SA using these criteria to determine its compliance status.

Can Muslims buy shares of Alvotech SA?

Muslim investors may consider investing in Alvotech SA if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Alvotech SA classified as NOT HALAL?

Musaffa determines the Shariah status of Alvotech SA by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Alvotech SA updated?

The Shariah compliance status of Alvotech SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Alvotech SA become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Alvotech SA?

You can check the latest Shariah compliance status of Alvotech SA on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

ALVO Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: April 16, 2026

Report Source: 2025 Annual Report

Analyst's Ratings for Alvotech SA (ALVO)

Based on 12 analysts giving stock ratings to Alvotech SA in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Alvotech SA. Stock Analysis ALVO

United States Health Care Small Cap Report: 2025 Annual

Alvotech is a biotechnology company, which engages in the development and manufacture of biosimilar medicines. The firm is focused on the development and manufacture of biosimilar medicines for patients globally. The company is engaged in developing a pipeline of monoclonal antibodies that target a variety of therapeutic areas including inflammatory diseases, oncology, and ophthalmology. The Company’s pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Its products pipeline includes AVT02, AVT04, AVT23, AVT03, AVT05, AVT06, AVT16, and AVT33. Its AVT02 is a monoclonal antibody and a biosimilar to Humira (adalimumab). AVT04 is a monoclonal antibody and a biosimilar candidate to Stelara (ustekinumab). The company has formed a network of strategic commercial partnerships to provide global reach and leverage expertise in markets that include the United States (U.S.), Europe, Japan, China, and other Asian countries and large parts of South America, Africa, and the Middle East.

Key Statistics of Alvotech SA (ALVO)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$3.27$3.42

Today's Open

$3.41

Volume

683.78K

P/E Ratio (TTM)

37.00

52 Week Range

$3.03$11.85

Market Cap

1.09B

Avg. Volume

391.85K

Dividend Yield

Financial Metrics & Statements of Alvotech SA (ALVO)

FAQ's for Alvotech SA (ALVO)

According to Musaffa’s Shariah screening methodology, Alvotech SA (ALVO) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.